Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Position Lowered by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC lessened its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) by 2.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 88,319 shares of the pharmacy operator’s stock after selling 2,068 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Walgreens Boots Alliance were worth $791,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Altrius Capital Management Inc boosted its holdings in shares of Walgreens Boots Alliance by 76.6% in the 3rd quarter. Altrius Capital Management Inc now owns 440,483 shares of the pharmacy operator’s stock valued at $3,947,000 after buying an additional 190,996 shares during the period. Tokio Marine Asset Management Co. Ltd. boosted its stake in Walgreens Boots Alliance by 21.8% in the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 25,343 shares of the pharmacy operator’s stock valued at $227,000 after acquiring an additional 4,534 shares during the period. OLD Second National Bank of Aurora grew its holdings in shares of Walgreens Boots Alliance by 35.1% during the third quarter. OLD Second National Bank of Aurora now owns 4,562 shares of the pharmacy operator’s stock valued at $41,000 after purchasing an additional 1,185 shares during the last quarter. Aptus Capital Advisors LLC raised its position in shares of Walgreens Boots Alliance by 37.6% during the 3rd quarter. Aptus Capital Advisors LLC now owns 14,445 shares of the pharmacy operator’s stock worth $129,000 after purchasing an additional 3,950 shares during the period. Finally, Aigen Investment Management LP bought a new stake in shares of Walgreens Boots Alliance in the 3rd quarter worth approximately $872,000. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ WBA opened at $8.73 on Wednesday. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $27.05. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. The stock has a fifty day moving average price of $9.13 and a two-hundred day moving average price of $11.39. The firm has a market cap of $7.55 billion, a P/E ratio of -0.87, a PEG ratio of 1.14 and a beta of 0.69.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last announced its earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business had revenue of $37.50 billion during the quarter, compared to analysts’ expectations of $35.75 billion. During the same quarter last year, the business posted $0.67 earnings per share. The company’s quarterly revenue was up 5.9% on a year-over-year basis. Research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.53 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Monday, November 18th will be issued a $0.25 dividend. The ex-dividend date is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 11.45%. Walgreens Boots Alliance’s payout ratio is currently -9.99%.

Analyst Ratings Changes

WBA has been the topic of several analyst reports. TD Cowen dropped their target price on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research report on Tuesday, October 22nd. Truist Financial cut their price objective on shares of Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating on the stock in a research report on Monday, October 7th. Evercore ISI boosted their target price on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a research note on Wednesday, October 16th. Jefferies Financial Group dropped their price target on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a research note on Wednesday, October 23rd. Finally, JPMorgan Chase & Co. reduced their price objective on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $12.88.

Check Out Our Latest Report on Walgreens Boots Alliance

Walgreens Boots Alliance Profile

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Read More

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.